By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panelists' discussion reveals a mixed sentiment towards First Solar, with concerns about policy risks, margin compression, and potential revenue misses outweighing optimism about thin-film technology and domestic manufacturing subsidies.
Risk: Policy shifts or Chinese module dumping could crater estimates and make the current valuation expensive.
Opportunity: First Solar's competitive edge in CdTe thin-film and US manufacturing could offer resilience amid policy support and potential IRA benefits.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Phoenix, Arizona-based First Solar, Inc. (FSLR) is a solar technology company that provides photovoltaic (PV) solar energy solutions in the United States and internationally. The company has a market cap of $23.6 billion and manufactures and sells PV solar modules using thin-film semiconductor technology, alongside conventional crystalline silicon PV solar modules.
FSLR shares have rallied the broader market over the past year and surged 63.2% compared to the S&P 500 Index ($SPX) 30.8% surge. However, in 2026, the stock has declined nearly 12.1%, underperforming the SPX’s 8.1% rise.
- Broadcom Hits a Bottleneck as OpenAI Revenue Concerns Claim Their First Casualty
- Palantir Stock Has a ‘High-Class Problem’: Demand for Its Software Is Far Outpacing Supply
Focusing on its industry benchmark, the State Street Technology Select Sector SPDR ETF (XLK) has risen 62.2% over the past year, outperforming the stock. In 2026, as well, XLK surged 22.6% and has rallied the stock.
On Apr. 30, FSLR stock rose 5.9% following the release of its mixed Q1 2026 earnings. The company’s revenue came in at $1 billion, missing Wall Street’s forecast. However, its adjusted EPS came in at $3.22, surpassing the Street’s estimates. First Solar expects full-year revenue in the range of $4.9 billion to $5.2 billion.
For the current year ending in December, analysts expect FSLR’s EPS to rise 23.7% year over year to $17.58. Moreover, the company has surpassed analysts’ consensus estimates in two of the past four quarters, while missing on two occasions.
Among the 32 analysts covering the stock, the consensus rating is a “Moderate Buy.” That’s based on 15 “Strong Buy” ratings, three “Moderate Buy,” 12 “Holds,” and two “Strong Sells.”
The configuration has remained more or less unchanged over the past month.
On May 4, UBS analyst Jon Windham maintained a “Buy” rating for FSLR stock and adjusted its price target from $300 to $290.
FSLR’s mean price target of $244.14 indicates a premium of 4.6% from the current market prices. Its Street-high target of $310 suggests a robust 32.8% upside potential from current price levels.
Four leading AI models discuss this article
"First Solar's current valuation is less a reflection of operational execution and more a proxy for the durability of U.S. protectionist solar policy."
First Solar's valuation is currently tethered to the assumption that domestic manufacturing subsidies under the Inflation Reduction Act (IRA) remain bulletproof. While the 23.7% EPS growth projection to $17.58 is impressive, the market is clearly pricing in political risk. The disconnect between the stock's 12.1% YTD decline and the broader tech sector's rally suggests investors are rotating out of policy-sensitive names. With a forward P/E sitting near 13x, the stock is cheap relative to its growth, but 'cheap' is a trap if domestic capacity utilization drops or if trade protectionism shifts. I am looking for margin compression as the company scales its Series 7 and 8 modules; revenue misses are a red flag for a growth-priced asset.
If the U.S. maintains aggressive trade barriers against Chinese solar imports, First Solar effectively holds a domestic monopoly that could justify a significant valuation re-rating despite political volatility.
"Analyst 'Moderate Buy' overstates upside amid ASP collapse and YTD underperformance, with low PT cluster exposing limited conviction."
FSLR's Moderate Buy consensus from 32 analysts looks tepid—15 Strong Buys but 14 Holds/Sells, with mean PT of $244 implying just 4.6% upside from ~$233 levels. YTD 2026 decline of 12.1% lags S&P (+8.1%) and XLK (+22.6%), signaling sector rotation away from solar amid Chinese overcapacity driving module ASPs down 40%+ YoY (industry data). Q1 revenue miss ($1B vs. est.) despite EPS beat underscores margin squeeze; FY guidance $4.9-5.2B suggests flat growth vs. prior ~$3.3B 2024 rev. Thin-film tech offers some edge, but backlog burn and policy risks loom large.
IRA tax credits and domestic content bonuses provide multi-year tailwinds, bolstering FSLR's US manufacturing moat against imports. Beating EPS 50% of recent quarters with 23.7% FY growth forecast could trigger re-rating if Q2 confirms.
"FSLR's revenue miss coupled with EPS beat suggests unsustainable margin expansion masking volume weakness, and analyst targets 4.6% upside don't compensate for re-rating risk if 2026 guidance proves optimistic."
FSLR's 2026 underperformance (-12.1% vs SPX +8.1%) despite analyst consensus 'Moderate Buy' and 23.7% EPS growth expectations signals a disconnect worth examining. The Q1 miss on revenue ($1B vs consensus) paired with EPS beat suggests margin expansion masking top-line weakness—a red flag in cyclical solar where capacity utilization matters. UBS cutting price target $300→$290 while maintaining 'Buy' is a quiet retreat. The $244 mean target implies only 4.6% upside, yet 15 'Strong Buys' remain on the board—analyst herding or outdated models? The real risk: if 2026 EPS guidance ($17.58) relies on margin leverage rather than volume recovery, any IRA policy shift or Chinese module dumping could crater estimates.
If FSLR's margin beat reflects genuine operational efficiency gains and the full-year guidance of $4.9–5.2B revenue (implying ~$1.2–1.3B per quarter) holds, the stock could re-rate higher as the market reprices sustainable profitability rather than cyclical volume plays.
"Long-run upside hinges on a durable project backlog and policy support, but near-term outcomes depend on whether Q2/Q3 volumes materialize."
The article frames First Solar as moderately bullish, citing a 63% prior-year rally, a Q1 revenue miss but EPS beat, and upside targets. Yet near-term demand remains a risk: utility-scale solar project cycles are lumpy, and revenue guidance hinges on backlog and pricing. First Solar’s competitive edge in CdTe thin-film and US manufacturing could offer resilience amid policy support and potential IRA benefits, but capex and working-capital demands pace free cash flow. If the pipeline softens or margins compress from pricing/cost shifts, the high optimism priced into targets could unwind before 2027.
The strongest counter: even with US manufacturing, a pullback in utility-scale demand or policy support could erase margin upside. A follow-on revenue miss could trigger significant multiple compression.
"Analysts are masking top-line stagnation with optimistic margin assumptions that will likely fail if volume growth doesn't materialize."
Claude highlights a critical contradiction: analyst 'Strong Buys' vs. a stagnant $244 price target. This isn't just herding; it’s a valuation trap. If analysts are modeling margin expansion to justify EPS growth while revenue remains flat, they are betting on operational perfection in a sector where Chinese dumping forces price compression. FSLR isn't a growth play anymore; it’s a policy-hedged utility. If Q2 shows volume contraction, that 13x forward P/E will look expensive, not cheap.
"FSLR's valuation discounts policy risk too deeply, ignoring tech-driven margin resilience and backlog visibility for multi-year growth."
Gemini, dubbing FSLR a 'policy-hedged utility' dismisses its thin-film tech moat and Series 7/8 scaling, which drove Q1 EPS beats despite revenue softness. With FY rev guidance up ~50% from 2024's $3.3B base and 23.7% EPS growth baked in, the 13x P/E isn't a trap—it's priced for perfection nobody questions enough on the upside. Chinese ASP crush hits c-Si hardest; FSLR's backlog insulates.
"Backlog provides tactical cover but doesn't solve structural demand risk if utility capex cycles soften."
Grok conflates backlog insulation with demand resilience—they're not the same. A backlog protects near-term revenue, but if utility-scale project starts decline (capex cycles, rate hikes), that buffer burns in 2–3 quarters. The 50% revenue growth from $3.3B assumes backlog conversion at current pricing. Chinese ASP pressure hits thin-film too if FSLR undercuts to maintain volume. Q2 backlog trends matter more than Q1 beats.
"Backlog isn't a moat; potential Q2 backlog weakness or delays could trigger multiple re-rating even with policy tailwinds."
Backlog opacity is a hazard: you can have a healthy backlog and still miss on realized revenue if project timelines slip or pricing renegotiations occur. Grok's 'insulates' claim assumes peak margins ride through; in solar, capex cycles and loan-financing conditions can push delays or cancellations. If Q2 backlog signals slower conversion or higher commissioning risk, 13x forward P/E may re-rate, regardless of IRA windfalls.
The panelists' discussion reveals a mixed sentiment towards First Solar, with concerns about policy risks, margin compression, and potential revenue misses outweighing optimism about thin-film technology and domestic manufacturing subsidies.
First Solar's competitive edge in CdTe thin-film and US manufacturing could offer resilience amid policy support and potential IRA benefits.
Policy shifts or Chinese module dumping could crater estimates and make the current valuation expensive.